Search clinical trials for: Placebo drug

Total 266286 results

University of Monastir

Not yet recruiting

Olive Leaf Extracts in the Control of Hypertension (Atherolive)

Hypertension
Trieu, Nguyen Thi, M.D.

Completed

Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes

HIV-1-infection | AIDS

Vietnam
Analgesic Solutions
Grünenthal GmbH

Completed

Training "Pain Connoisseurs" for Efficient Analgesic Proof-of-Concept Studies

Painful Diabetic Neuropathy (PDN)

United States
Azienda Ospedaliera Universitaria Integrata Verona

Unknown

Effects of Intake of a Polysaccharides Mix on Metabolism, Hormones and Satiety in Obese Children.

Obesity

Italy
Diabetes Foundation, India
Institute of Home Economics, India

Completed

Effect of Oral Cinnamon Intervention in Metabolic Syndrome

Metabolic Syndrome

India
University of Electronic Science and Technology...

Recruiting

The Effects of Intranasal and Oral Administration of Oxytocin on Responses to Emotional Scenes

Healthy

China
Aspireo Pharmaceuticals Limited

Completed

Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173

Healthy
Infinity Pharmaceuticals, Inc.
Bristol-Myers Squibb

Completed

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Solid Tumor | Bladder Cancer | Advanced Cancer | Urothelial Carcinoma

France, Spain, United States, Italy, Czechia, Poland, Serbia
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Xuanwu Hospital, Beijing

Completed

Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets

Parkinson Disease

China
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
Italfarmaco

Completed

Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy

Becker Muscular Dystrophy

Netherlands, Italy
Rochester General Hospital

Terminated

Oral Vancomycin for Preventing Clostridium Difficile Recurrence

Clostridium Difficile Infection

United States
Algenis SpA

Completed

Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study

Back Pain | Acute Pain

Chile
Massachusetts General Hospital
National Institute of Mental Health (NIMH)

Completed

Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression

Depression

United States
National Institute of Mental Health (NIMH)

Completed

Antidepressant Effects of NR2B in Major Depression

Major Depression

United States
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Children's Hospital Los Angeles

Active, not recruiting

The Gut-Brain Study

Autism Spectrum Disorder (ASD) | Gastro-Intestinal Disorder

United States
Calliditas Therapeutics AB

Completed

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Primary Biliary Cirrhosis

United States, Israel, Belgium, Germany, United Kingdom, Spain, Greece, Canada, Italy
McMaster University
BioGaia AB

Completed

Probiotics and Capsaicin Evoked Coughs (PCEC)

Atopic Asthma

Canada
AB Science

Completed

Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Asthma

Spain, Bulgaria, Czechia, France, Hungary, India
Actinogen Medical
ICON plc

Completed

Xanamem™ in Healthy Elderly Subjects (XanaHES)

Cognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre Neuropathy

Australia
Creabilis SA
Aalborg University Hospital

Completed

A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers

Neuropathic Pain

Denmark
Boehringer Ingelheim

Completed

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Healthy

Germany
Pharmena North America

Completed

Safety of a Hypolipidemic Agent in Healthy Normal Volunteers (PNAI-002)

Hyperlipidemia

United States
Barts & The London NHS Trust
Barts and the London School of Medicine and Dentistry

Completed

Prevention of Metabolic Complications of Glucocorticoid Excess

Iatrogenic Cushing Disease

United Kingdom
Allakos Inc.

Recruiting

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

Healthy Participants | Chronic Spontaneous Urticaria

United States
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

Diabetes Mellitus, Type 2

China
Green Cross Corporation
Korean Center for Disease Control and Prevention

Completed

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 (GC1109)

Anthrax

Korea, Republic of
Sunnybrook Health Sciences Centre

Active, not recruiting

Use of TXA to Prevent Postpartum Hemorrhage (TAPPH-1)

Post Partum Hemorrhage

Canada
Zealand Pharma

Completed

Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM

Hypoglycemia | Diabetes Mellitus, Type 1

United States
Tolerion, Inc.

Withdrawn

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN) (DAWN)

Diabetes Mellitus, Type 1

United States
AB Science

Completed

Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels

Asthma

Malaysia, Argentina, Peru, Philippines, Ukraine
Tolerion, Inc.

Withdrawn

Diabetes AutoimmunitY Withdrawn in Established Patients (DAY) (DAY)

Diabetes Mellitus, Type 1
Novartis Pharmaceuticals
Erasmus Medical Center; Fundacion Clinic per a la Recerca Biomédica; University... and other collaborators

Completed

Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection (iBEST-1)

Non-cystic Fibrosis Bronchiectasis

Germany, Belgium, France, United Kingdom, Spain, Italy
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC

Prostate Cancer | Castration-resistant Prostate Cancer

China
University of Puerto Rico
Merck Sharp & Dohme LLC

Terminated

Alvimopan Use in Polytraumatized Patients

Post Operative Ileus

Puerto Rico
University of Waterloo

Completed

Glutamate Supplementation in Young Men

Healthy

Canada
Indonesia University

Completed

Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients

Oxidative Stress | Cerebral Stroke | Malondialdehyde

Indonesia
National Institute of Allergy and Infectious Diseases...

Completed

MVA Post-Event: Administration Timing and Boost Study

Smallpox

United States
Sheba Medical Center

Withdrawn

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Psoriasis

Israel
University of California, San Diego
Center for Medicinal Cannabis Research; California Department of Cannabis Control...

Recruiting

Role of CBD in Improving Alexithymia (ACBD)

HIV | Alexithymia

United States
Universitaire Ziekenhuizen KU Leuven
Intercept Pharmaceuticals

Recruiting

The Effect of Obeticholic Acid in Healthy Volunteers (OCARINA)

Healthy

Belgium
Biosergen AS
Nucleus Network Ltd; Select Pharma Pty Ltd; Greenlight Clinical

Recruiting

A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.

Invasive Fungal Infections

Australia
Azidus Brasil
Farmoquimica S.A.

Completed

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms (Probiatop)

Signs and Symptoms, Digestive

Brazil
Tolerion, Inc.

Active, not recruiting

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients (SUNRISE)

Diabetes Mellitus, Type 1

United States
Canopy Growth Corporation
Centre for Addiction and Mental Health; McMaster University

Withdrawn

CHI-902 for Treatment of Social Anxiety Disorder

Social Anxiety Disorder

Canada
Immune Design

Terminated

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Sarcoma | Soft Tissue Sarcoma | Cancer | Synovial Sarcoma | Metastatic Sarcoma

United States, Canada
University of Illinois at Chicago

Withdrawn

Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease

Inflammatory Bowel Diseases | Crohn Disease | Cannabis
Catalysis SL

Completed

Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

Papillomavirus Infections | Papilloma Viral Infection | Esophageal Viral Wart | Esophageal Verrucous Carcinoma

Cuba
Biotie Therapies Inc.

Terminated

Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients (TOZ-PD)

Idiopathic Parkinson's Disease

Germany, Spain, Canada, United States, Italy, Austria, Czechia

Search clinical trials for: Placebo drug

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations